Popular Articles

POZEN Submits New Drug Application For VIMOVO™ (PN 400)
POZEN Inc. (NASDAQ:POZN), announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO™ (PN 400), the combination of enteric coated (EC) naproxen and immediate release esomeprazole. POZEN and AstraZeneca entered into a global co-development agreement for VIMOVO in August 2006. Pending regulatory approval, the proposed trade name is VIMOVO and the proposed indications are for the signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients who are at risk for developing NSAID-associated ulcers.
generic viagra online
Schools Failing Children With Sickle Cell
The lack of awareness in schools is having a serious impact on the education of children with Sickle Cell, according to research published in the British Education Research Journal this month.
plastic surgery before after
News of the day
Vertex Initiates Phase 3 Registration Program For VX-770, An Oral CFTR Potentiator Targeting The Defective Protein Responsible For Cystic Fibrosis
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the initiation of a Phase 3 registration program for VX-770, an investigational Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) potentiator that targets the defective CFTR protein that causes cystic fibrosis (CF). The VX-770 registration program will consist of three clinical trials, including a primary 48-week Phase 3 trial that is currently open to enrollment of patients aged 12 years and older who carry the G551D mutation on at least one allele. Two additional trials will evaluate VX-770 in patients aged 6 to 11 years with the G551D mutation on at least one allele and in patients homozygous for the F508del mutation, respectively.
Nutrition

Protein In The Envelope Enclosing The Cell Nucleus A New Piece Of The Puzzle In Research On Cancer And Stem Cells?

A research team led by Professor Einar Hallberg at the Department of Life Sciences at Sç¶dertç¶rn University in Sweden has discovered a new protein in the inner membrane of the cell nucleus. This protein may play an important role in cell division and now provides a new piece of the puzzle to study in cancer research. All living organisms are made up of cells. The cell consists of different "compartments" that have different functions. In one of the compartments, the cell nucleus, there is genetic information about how the organism"s proteins should look like, and when they should be produced. The cell nucleus is enclosed by a double lipid membrane that is called the nuclear envelope. All transports in and out of the nucleus take place through pores in the nuclear envelope. It is estimated that there are some 100 different proteins in the nuclear envelope, but scientists do not yet know precisely how they function. The protein that the Sodertorn researchers have now discovered, called Samp1, normally exists in the membrane envelope that surrounds the cell nucleus (Fig. 1). During cell division it turned out that it was part of the process that distributes the chromosomes evenly between the daughter cells, the so-called "mitotic spindle" (Fig. 2). The protein was therefore named Samp1 (Spindle associated membrane protein 1). "This discovery was unexpected, since it was previously not believed that integral proteins that are embedded in membranes could be in the mitotic spindle. Nor was it previously understood what functions such proteins would have there," says Professor Hallberg. The distribution of chromosomes during cell division is extremely rigidly regulated, and the slightest error can lead to the development of tumors. Samp1 will now be a key piece of the puzzle to study in cancer research. The study, which was recently published in Journal of Cell Science "An integral protein of the inner nuclear membrane localizes to the mitotic spindle in mammalian cells", Journal of Cell Science 122, 2100-2107), was part of a doctoral thesis at the Karolinska Institutet that was defended at Sç¶dertç¶rn University by Dr. Charlotta Buch on February 20 this year. Einar Hallberg"s research team discovered in their study that the Samp1 protein has connections to the cell skeleton outside the cell nucleus. This takes place between cell divisions, when the protein is in the inner membrane of the cell nucleus. It is possible that Samp1 may play an important role when mechanical signals from the outside of the cell are transmitted to the genes in the cell nucleus. Professor Hallberg"s research group is now focusing on investigating what role Samp1 might have in the transmission of mechanical signals from the outside of the cell to the genes. Recently mechanical signaling has been shown to be extremely important in how the body"s cells are organized to form various organs. For instance, cultured stem cells develop into nerve cells, muscle cells, or bone cells depending on the stiffness of the material they grow on. Increased knowledge about mechanical signaling is of great importance to stem cell research and future regenerative medicine. Vetenskapsradet (The Swedish Research Council)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):